Annual FCF
-$156.42 M
-$30.92 M-24.64%
December 31, 2023
Summary
- As of February 8, 2025, COGT annual free cash flow is -$156.42 million, with the most recent change of -$30.92 million (-24.64%) on December 31, 2023.
- During the last 3 years, COGT annual FCF has fallen by -$120.57 million (-336.32%).
- COGT annual FCF is now -1094.91% below its all-time high of $15.72 million, reached on December 31, 2015.
Performance
COGT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$52.26 M
-$9.41 M-21.97%
September 30, 2024
Summary
- As of February 8, 2025, COGT quarterly free cash flow is -$52.26 million, with the most recent change of -$9.41 million (-21.97%) on September 30, 2024.
- Over the past year, COGT quarterly FCF has dropped by -$9.41 million (-21.97%).
- COGT quarterly FCF is now -774.27% below its all-time high of -$5.98 million, reached on June 30, 2017.
Performance
COGT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$192.10 M
-$14.17 M-7.97%
September 30, 2024
Summary
- As of February 8, 2025, COGT TTM free cash flow is -$192.10 million, with the most recent change of -$14.17 million (-7.97%) on September 30, 2024.
- Over the past year, COGT TTM FCF has dropped by -$14.17 million (-7.97%).
- COGT TTM FCF is now -2431.59% below its all-time high of -$7.59 million, reached on March 31, 2017.
Performance
COGT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
COGT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.6% | -22.0% | -8.0% |
| 3 y3 years | -336.3% | -242.2% | -294.9% |
| 5 y5 years | -373.4% | -527.9% | -451.1% |
COGT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -158.6% | at low | -146.4% | +0.6% | -217.6% | at low |
| 5 y | 5-year | -336.3% | at low | -562.2% | +0.6% | -451.1% | at low |
| alltime | all time | -1094.9% | at low | -774.3% | +0.6% | -2431.6% | at low |
Cogent Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$52.26 M(+22.0%) | -$192.10 M(+8.0%) |
| Jun 2024 | - | -$42.85 M(-18.5%) | -$177.93 M(+5.7%) |
| Mar 2024 | - | -$52.60 M(+18.5%) | -$168.40 M(+7.7%) |
| Dec 2023 | -$156.42 M(+24.6%) | -$44.38 M(+16.5%) | -$156.42 M(+9.1%) |
| Sep 2023 | - | -$38.09 M(+14.3%) | -$143.41 M(+0.2%) |
| Jun 2023 | - | -$33.32 M(-18.0%) | -$143.07 M(+4.2%) |
| Mar 2023 | - | -$40.62 M(+29.5%) | -$137.35 M(+9.4%) |
| Dec 2022 | -$125.50 M(+107.5%) | -$31.38 M(-16.9%) | -$125.50 M(+8.8%) |
| Sep 2022 | - | -$37.75 M(+36.8%) | -$115.34 M(+24.2%) |
| Jun 2022 | - | -$27.60 M(-4.1%) | -$92.86 M(+19.2%) |
| Mar 2022 | - | -$28.77 M(+35.7%) | -$77.89 M(+28.8%) |
| Dec 2021 | -$60.48 M(+68.7%) | -$21.21 M(+38.9%) | -$60.48 M(+24.4%) |
| Sep 2021 | - | -$15.27 M(+20.9%) | -$48.64 M(+11.5%) |
| Jun 2021 | - | -$12.63 M(+11.2%) | -$43.63 M(+11.0%) |
| Mar 2021 | - | -$11.37 M(+21.4%) | -$39.32 M(+9.7%) |
| Dec 2020 | -$35.85 M | -$9.37 M(-8.8%) | -$35.85 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$10.27 M(+23.3%) | -$34.94 M(+0.2%) |
| Jun 2020 | - | -$8.32 M(+5.5%) | -$34.86 M(-8.0%) |
| Mar 2020 | - | -$7.89 M(-6.7%) | -$37.88 M(-8.8%) |
| Dec 2019 | -$41.55 M(+25.8%) | -$8.46 M(-17.0%) | -$41.55 M(-1.3%) |
| Sep 2019 | - | -$10.19 M(-10.2%) | -$42.11 M(+6.4%) |
| Jun 2019 | - | -$11.34 M(-1.9%) | -$39.59 M(+8.3%) |
| Mar 2019 | - | -$11.56 M(+28.2%) | -$36.54 M(+10.6%) |
| Dec 2018 | -$33.04 M(+23.5%) | -$9.02 M(+17.7%) | -$33.04 M(+7.8%) |
| Sep 2018 | - | -$7.66 M(-7.7%) | -$30.63 M(+3.7%) |
| Jun 2018 | - | -$8.30 M(+3.0%) | -$29.54 M(+8.5%) |
| Mar 2018 | - | -$8.06 M(+21.8%) | -$27.21 M(+1.7%) |
| Dec 2017 | -$26.75 M(+21.9%) | -$6.62 M(+0.8%) | -$26.75 M(+32.9%) |
| Sep 2017 | - | -$6.57 M(+9.8%) | -$20.13 M(+48.4%) |
| Jun 2017 | - | -$5.98 M(-21.2%) | -$13.57 M(+78.8%) |
| Mar 2017 | - | -$7.59 M | -$7.59 M |
| Dec 2016 | -$21.95 M(-239.6%) | - | - |
| Dec 2015 | $15.72 M | - | - |
FAQ
- What is Cogent Biosciences annual free cash flow?
- What is the all time high annual FCF for Cogent Biosciences?
- What is Cogent Biosciences annual FCF year-on-year change?
- What is Cogent Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Cogent Biosciences?
- What is Cogent Biosciences quarterly FCF year-on-year change?
- What is Cogent Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Cogent Biosciences?
- What is Cogent Biosciences TTM FCF year-on-year change?
What is Cogent Biosciences annual free cash flow?
The current annual FCF of COGT is -$156.42 M
What is the all time high annual FCF for Cogent Biosciences?
Cogent Biosciences all-time high annual free cash flow is $15.72 M
What is Cogent Biosciences annual FCF year-on-year change?
Over the past year, COGT annual free cash flow has changed by -$30.92 M (-24.64%)
What is Cogent Biosciences quarterly free cash flow?
The current quarterly FCF of COGT is -$52.26 M
What is the all time high quarterly FCF for Cogent Biosciences?
Cogent Biosciences all-time high quarterly free cash flow is -$5.98 M
What is Cogent Biosciences quarterly FCF year-on-year change?
Over the past year, COGT quarterly free cash flow has changed by -$9.41 M (-21.97%)
What is Cogent Biosciences TTM free cash flow?
The current TTM FCF of COGT is -$192.10 M
What is the all time high TTM FCF for Cogent Biosciences?
Cogent Biosciences all-time high TTM free cash flow is -$7.59 M
What is Cogent Biosciences TTM FCF year-on-year change?
Over the past year, COGT TTM free cash flow has changed by -$14.17 M (-7.97%)